- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Broadlane cuts deals with R2 and Varian
Provider of cost management services Broadlane has designated R2 Technology as its exclusive provider of computer-aided detection systems. The company also cut a three-year agreement with Varian Medical Systems for the supply of radiotherapy systems. The
Provider of cost management services Broadlane has designated R2 Technology as its exclusive provider of computer-aided detection systems. The company also cut a three-year agreement with Varian Medical Systems for the supply of radiotherapy systems. The exclusive agreement with R2, which extends to Dec. 31, 2004, provides access for Broadlane customers to R2's ImageChecker CAD mammography system. Varian will offer Broadlane institutions a range of radiotherapy products including its Clinac medical linear accelerators, Millennium multileaf collimators, and PortalVision electronic portal imaging systems. Broadlane customers will also have access to imaging products from GE Medical Systems that Varian distributes in North America under a special See and Treat Cancer Care partnership agreement.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
